POSTER SESSION IV
Tuesday, March 20, 2012 — 1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
ENDOCRINE PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
16
Risk Stratification of Follicular Variant of Papillary Thyroid Carcinoma
(624)
M Vivero, S Kraft, JA Barletta - Brigham and Women´s Hospital, Boston, MA; Massachusetts General Hospital, Boston, MA
microRNA Expression Array Identifies Novel Diagnostic Markers for Conventional and Oncocytic Follicular Thyroid Carcinomas
(589)
M Dettmer, MB Durso, P Komminoth, H Moch, A Perren, YE Nikiforov, MN Nikiforova - University of Pittsburgh, Pittsburgh; Triemlispital, Zurich, Switzerland; University Hospital, Zurich, Switzerland; University of Bern, Bern, Switzerland
Expression of Epithelial-Mesenchymal Transition Regulators Slug and Twist in Thyroid Carcinomas
(586)
D Buehler, H Hardin, W Shan, W Rehrauer, H Chen, RV Lloyd - University of Wisconsin School of Medicine and Public Health, Madison, WI
Rate of Extrathyroidal Extension and Lymph Node Metastases in Papillary Thyroid Carcinoma with Tall Cell Features
(618)
F Rosenblum Donath, S Kraft, JA Barletta - Brigham and Women´s Hospital, Boston, MA; Massachusetts General Hospital, Boston, MA
Papillary Thyroid Microcarcinoma: Clinicopathological Correlation with BRAF V600E Mutation
(623)
RK Virk, A Finkelstein, A Prasad, P Hui, T Carling, SA Roman, JA Sosa, R Udelsman, M Prasad - Yale School of Medicine, New Haven, CT; New York University, New York, NY; Hartford Hospital, Hartford, CT
Less Tumor Distance to Thyroid Pseudo Capsule Is Associated with Local Recurrence and Distant Metastases of Microscopic Papillary Carcinoma
(592)
A Gamboa-Dominguez, B Camacho-Dominguez, M Chapa- Ibarguengoitia, V Rosas-Camargo, O Gonzalez-Trevino - Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, DF, Mexico
Histopathologic Characteristics of Thyroid Tumors Positive for BRAF V600E Mutation
(613)
W Nugent, C Coyne, MN Nikiforova, YE Nikiforov - University of Pittsburgh, Pittsburgh
Validation of BRAF V600E Mutation Using Qiagen Rotor- Gene Analysis System
(628)
R Zreik, E Castro-Echeverry, C Chisholm, D Smith, J Gildon, S Walker, K Walker, L Sayage-Rabie, A Rao - Scott & White Memorial Hospital, Temple, TX
Follicular Variant of Papillary Thyroid Carcinoma (FVPTC): Histological Features, BRAF Mutation, and Lymph Node Metastasis
(585)
S Bose, SK Mohanty, C Singh, A Riley-Portuges, W Sacks, AE Walts - Cedars-Sinai Medical Center, Los Angeles, CA; University of Minnesota, Minneapolis, MN
Accuracy and Reproducibility of Histologic Features Predictive of BRAF V600E Mutation in Papillary Thyroid Carcinoma
(622)
RK Virk, A Finkelstein, A Prasad, P Hui, D Chhieng, C Theoharis, J Gibson, S Roman, M Prasad - Yale School of Medicine, New Haven, CT; New York University, New York, NY; Hartford Hospital, Hartford, CT
Thyroid Rests or Malignancy: Can BRAF Mutation Analysis Help in the Differential Diagnosis?
(583)
A Best, C Chisholm, D Smith, MK Lopez, K Walker, RS Beissner, A Rao - Scott & White Memorial Hospital and Texas A&M Health Science Center College of Medicine, Temple, TX
Molecular Features of Follicular Variant Papillary Carcinoma of Thyroid: Comparison of Areas with or without Classical Nuclear Features
(597)
G Guney, G Guler Tezel, K Kosemehmetoglu, E Yilmaz, R Ersoy, B Cakir, G Guler - Yildirim Beyazit University Ankara Ataturk Research and Education Hospital, Ankara, Turkey; Hacettepe University, Ankara, Turkey
Tall Cell Variant of Papillary thyroid Carcinoma – How Many Tall Cells Are Needed?
(590)
MS Dettmer, A Schmitt, H Steinert, H Moch, P Komminoth, A Perren - University of Pittsburgh, Pittsburgh, PA; University of Bern, Bern, Switzerland; University Hospital Zurich, Zurich, Switzerland; Triemlispital, Zurich, Zurich, Switzerland
Clinico-Pathological and Molecular Characteristics of Tall Cell Variant of Papillary Thyroid Microcarcinoma
(582)
J Bernstein, R Virk, WH Westra, G Tallini, P Hui, R Udelsman, CT Sasaki, S Roman, JA Sosa, ML Prasad - Yale School of Medicine, New Haven, CT; Johns Hopkins School of Medicine, Baltimore, MD; Bologna University School of Medicine, Bologna, Italy
The Definition of ´Sizable´ Blood Vessel as a Histologic Clue of Extrathyroidal Tumor Extension Can Be Clarified by Morphometric Analysis of Intra- and Extrathryroidal Blood Vessels
(601)
HM Jeon, B Lim, SW Hong - Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea
Cribriform Morular Variant of Papillary Thyroid Carcinoma: Morphological Characteristics of an Unusual Tumor That Distinguish the Inherited and Sporadic Subtypes
(608)
CM Kovacs, V Nose - University of Miami, Miami, FL; Jackson Memorial Hospital, Miami, FL
Micro-RNA Target Identification, Expression and Immunophenotype Analysis: Possible Role for TRDMT1 in the Pathogenesis of Papillary Thyroid Carcinoma
(617)
A Rangel Filho, V Nose - University of Miami, Miami, FL
The Prognostic Relevance of Nuclear Factor-kB Activation in Papillary Thyroid Carcinoma
(616)
J-S Pyo, G Kang, D-H Kim, SW Chae, JH Sohn - Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
IQGAP1 Copy Number in Follicular-Patterned Lesions of the Thyroid – A Pilot Study
(627)
AE Walts, A Riley-Portuges, S Bose - Cedars-Sinai Medical Center, Los Angeles, CA
Aberrant Expression of the Runx Family Genes in Thyroid Carcinomas
(605)
T Kondo, D Niu, T Nakazawa, T Kawasaki, N Oishi, K Mochizuki, T Yamane, R Katoh - University of Yamanashi, Yamanashi, Japan
Primary Benign Parathyroid Proliferative Lesions: Growth Factor Pathways and Stromal Interaction Responsible of the Growth Patterns
(610)
R Lam, A Blanes, SJ Diaz-Cano - King´s College Hospital, London, United Kingdom; University of Malaga School of Medicine, Malaga, Spain
Identification of New Target Proteins in Parathyroid Carcinomas
(611)
O Mete, B Erovic, J Irish, SL Asa - University Health Network, Toronto, ON, Canada
Use of a 92-Gene Molecular Classifier To Predict the Site of Origin for Primary and Metastatic Tumors with Neuroendocrine Differentiation
(604)
SE Kerr, CA Schnabel, PS Sullivan, Y Zhang, V Singh, B Carey, MG Erlander, WE Highsmith, EF Brachtel, SM Dry - Mayo Clinic, Rochester, MN; bioTheranostics, Inc., San Diego, CA; University of California at Los Angeles, Los Angeles, CA; Massachussetts General Hospital, Boston, MA
Proposal for a Simplified Mib1 Assessment in Pancreatic Endocrine Tumors
(584)
A Blank, L Boos, I Zlobec, P Komminoth, A Perren, AM Schmitt - University of Bern, Bern, Switzerland; Technical University Munich, Munich, Germany; City Hospital Triemli, Zurich, Switzerland
Endocrine Tumors Display Site-Specific Alterations in Wnt Signaling, the mTOR Pathway, and Chromatin Remodeling
(596)
PS Ginter, NC Panarelli, RK Yantiss, T Scognamiglio, Y-T Chen - Weill Cornell Medical College, New York
An Analysis of Protein Expressions of Pancreatic Neuroendocrine Tumors of Japanease Patients According to 2010 WHO Classification
(603)
A Kasajima, K Ishida, F Fujishima, F Motoi, H Ootsuka, Y Nakamura, M Watanabe, M Unno, H Sasano - Tohoku University Hospital, Sendai, Japan
Immunohistochemical Detection of Somatostatin Receptor 2a (SSTR2a) and mTOR in the Cases of Neuroendocrine Tumors (NETs) for Appropriate Biotherapy; Experience of a Large Series of Referred Cases
(614)
RY Osamura, M Matsuda, T Itoh, C Inomoto, H Kajiwara - Center for Diagnostic Pathology International University of Health and Welfare(IUHW), IUHW Mita Hospital, Minato-ku, Tokyo, Japan; Tokai University School of Medicine, Isehara, Japan
The Role of MicroRNA Expression in the Diagnosis of Adrenocortical Carcinomas. A Marker of Poor Prognostic Tumors
(626)
BA Walter, S Barak, A Fojo, MJ Merino - NCI, NIH, Bethesda
Cytoplasmic Staining of OCT4 in Pheochromocytoma Is Highly Sensitive and Specific: A Novel Immunohistochemical Finding
(579)
RE Alexander, DJ Grignon, MT Idrees - Indiana University School of Medicine, Indianapolis, IN
ACTH-Independent Multinodular Adrenal Hyperplasia with Dominant Nodule: Expression Profile Support a Neoplastic- Like and Non-Functional Presentation
(595)
E Garratt, A Blanes, SJ Diaz-Cano - Barts and The London Hospitals, London, United Kingdom; University of Malaga School of Medicine, Malaga, Spain; King´s College Hospital, London, United Kingdom
Evaluation of ScreenCell® Devices for the Detection of Circulating Tumor Cells in Adrenocortical Carcinoma
(619)
C Scatena, F Salvianti, P Pinzani, M Luconi, M Mannelli, D Massi, G Nesi - University of Florence, Florence, Italy
Are Adrenal Lesions Part of the Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC)?
(621)
B Shuch, M Linehan, MJ Merino - NCI, Bethesda, MD
Large Adrenal Cortical Adenomas with Extensive Myelolipomatous Metaplasia: Upregulation of Jak-Stat Pathway and Solitary Fibrous Type Stromal Reaction
(594)
E Garratt, A Blanes, SJ Diaz-Cano - Barts and The London Hospitals, London, United Kingdom; University of Malaga School of Medicine, Malaga, Spain; King´s College Hospital, London, United Kingdom
Cell Cycle Regulators in Pheochromocytomas (PCTs) and Paragangliomas (PGLs) and Correlation with SDHx Status and FGFR4 Genotype
(587)
CA Cassol, SL Asa - University Health Network, Toronto, ON, Canada
button next to any title to add to Itinerary Planner...
Add
